Evidence map›Paper›PMID 17307212›Full record

ArticleVirology2007

Virus-specific T cell responses in macaques acutely infected with SHIV(sf162p3).

Bapi Pahar, Xiaolei Wang, Jason Dufour, Andrew A Lackner, Ronald S Veazey

Open access · greenAbstract read
In one paragraph

Article in Virology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Animal models for microbicide studies.Current HIV research · 2012
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Bapi PaharDivision of Immunology, Tulane National Primate Research Center, Tulane University School of Medicine, 18703 Three Rivers Road, Covington, LA 70433, USA.
Xiaolei Wang
Jason Dufour
Andrew A Lackner
Ronald S Veazey
Tulane University · US

Funding

Tulane NPRC SPF Sheltered Outdoor Enclosure ExpansionP51OD011104 · OD · TULANE UNIVERSITY OF LOUISIANA · PI L Lee HAMM · 2012 to 2026
$142.4M
ZCM:A NOVEL BROAD-SPECTRUM MICROBICIDE FOR SEXUALLY TRANSMITTED INFECTIONSP51RR000164 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI VEAZEY, RONALD S. · 1985 to 2011
$100.1M
Topical Agents to Prevent Mucosal HIV TransmissionP01AI051649 · NIAID · UNIVERSITY OF GENEVA · PI LEDERMAN, MICHAEL MARCEL · 2002 to 2006
$7.5M
Evaluation of AFE Inhibitors for Protection from SHIV Vaginal ChallengeU19AI065413 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI MOORE, JOHN P · 2005 to 2007
$4.5M
Mechanisms of CD4 Depletion and Proliferation in SIVR01AI049080 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI VEAZEY, RONALD S. · 2001 to 2006
$2.2M
EXPANSION OF BSL2 CAGING FOR INFECTIOUS DISEASE RESEARCHG20RR019628 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI BOHM, RUDOLF P · 2004 to 2004
$700k
BLDG D RENOV-ANIMAL RESOURCES IMPROVEMENTSG20RR016930 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI BLANCHARD, JAMES L · 2001 to 2001
$700k
BREEDING FACILITY AND SECURITY IMPROVEMENTG20RR018397 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI LACKNER, ANDREW A · 2003 to 2003
$697k
High-speed cell sorterS10RR016963 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI VEAZEY, RONALD S. · 2002 to 2002
$428k
IMPROVEMENT OF ANIMAL RESOURCESG20RR013466 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI BLANCHARD, JAMES L · 1998 to 1998
–
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTIONC06RR012112 · NCRR · TULANE UNIVERSITY OF LOUISIANA · PI GERONE, PETER J · 1996 to 1996
–
NCRR NIH HHS G20 RR013466NCRR NIH HHS G20 RR016930NCRR NIH HHS G20 RR018397NCRR NIH HHS G20 RR019628NCRR NIH HHS P51 RR000164NCRR NIH HHS RR00164NCRR NIH HHS RR012112NCRR NIH HHS RR013466NCRR NIH HHS RR016930NCRR NIH HHS RR018397NCRR NIH HHS RR019628NCRR NIH HHS S10 RR016963NIAID NIH HHS AI051649NIAID NIH HHS AI065413NIAID NIH HHS AI49080NIAID NIH HHS P01 AI051649NIAID NIH HHS R01 AI049080NIAID NIH HHS U19 AI065413NIH HHS P51 OD011104
6 · The paper itself

Abstract

CD4(+) T helper and CD8(+) cytotoxic T lymphocyte responses are believed to play an important role in the control of primary HIV and SIV infection. However, the role of these cells in macaques acutely infected with SHIV(sf162p3) has not been well characterized. In this study, ten adult rhesus macaques were intravaginally infected with SHIV(sf162p3), and antigen-specific cytokine responses to SHIV-Tat, Nef, Gag and Env peptide pools were examined through 70 days post inoculation (p.i.) using ELISPOT and/or cytokine flow cytometry (CFC). Peak plasma viral replication occurred between 14 and 21 days p.i. followed by low to undetectable plasma viremia by 70 days of infection in most macaques. Although some animals had strong virus-specific cellular immune responses, many had weak or minimal responses that did not correlate with the post peak decline in plasma viremia.

Indexed as

Acute DiseaseAnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCell DivisionFemaleHIV AntigensHIV InfectionsImmunologic MemoryInterferon-gammaMacaca mulattaSimian Acquired Immunodeficiency SyndromeT-LymphocytesTumor Necrosis Factor-alphaViremiaHIV AntigensInterferon-gammaTumor Necrosis Factor-alpha

Identifiers

PMID17307212
PMCPMC1959567
OpenAlexW2049921779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.